Clinical Human Papillomavirus Detection Forecasts Cervical Cancer Risk in Women Over 18 Years of Follow-Up
2012; Lippincott Williams & Wilkins; Volume: 30; Issue: 25 Linguagem: Inglês
10.1200/jco.2011.38.8389
ISSN1527-7755
AutoresPhilip E. Castle, Andrew G. Glass, Brenda B. Rush, David R. Scott, Nicolas Wentzensen, Julia C. Gage, Julie Buckland, Greg Rydzak, Attila T. Lörincz, Sholom Wacholder,
Tópico(s)Reproductive tract infections research
ResumoTo describe the long-term (≥ 10 years) benefits of clinical human papillomavirus (HPV) DNA testing for cervical precancer and cancer risk prediction.
Referência(s)